HU164525B - - Google Patents

Info

Publication number
HU164525B
HU164525B HUTA1163A HUTA001163A HU164525B HU 164525 B HU164525 B HU 164525B HU TA1163 A HUTA1163 A HU TA1163A HU TA001163 A HUTA001163 A HU TA001163A HU 164525 B HU164525 B HU 164525B
Authority
HU
Hungary
Application number
HUTA1163A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU164525B publication Critical patent/HU164525B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUTA1163A 1970-12-28 1971-12-23 HU164525B (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP45124064A JPS4935635B1 (https=) 1970-12-28 1970-12-28

Publications (1)

Publication Number Publication Date
HU164525B true HU164525B (https=) 1974-02-28

Family

ID=14876047

Family Applications (1)

Application Number Title Priority Date Filing Date
HUTA1163A HU164525B (https=) 1970-12-28 1971-12-23

Country Status (8)

Country Link
US (1) US3819613A (https=)
JP (1) JPS4935635B1 (https=)
BE (1) BE777223A (https=)
CA (1) CA952102A (https=)
DE (1) DE2163790A1 (https=)
FR (1) FR2120040A1 (https=)
HU (1) HU164525B (https=)
NL (1) NL7117787A (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4157443A (en) * 1976-11-11 1979-06-05 Ciba-Geigy Corporation V-Triazolyl-[4,5-d]-pyrimidines
US5017578A (en) * 1989-06-09 1991-05-21 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents
US5155098A (en) * 1989-06-09 1992-10-13 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines, and pharmaceutical compositions and methods employing them
US5278150A (en) * 1992-04-24 1994-01-11 Whitby Research, Inc. 2-hydrazoadenosines and their utility for the treatmeat of vascular conditions
DK62592D0 (https=) * 1992-05-14 1992-05-14 Novo Nordisk As
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
EP0704215A3 (en) * 1994-06-02 1998-04-01 Takeda Chemical Industries, Ltd. Inhibitor of vascular permeability enhancer
JP2003506310A (ja) 1997-10-07 2003-02-18 リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア ヘパリン及びアデノシドa2アゴニストの組合せで、又はアデノシンでの閉塞性末梢血管疾患及び冠状動脈疾患の治療
US5972903A (en) * 1997-10-07 1999-10-26 Regents Of The University Of California Corporation Method for promoting angiogenesis using heparin and adenosine
CN103087133B (zh) * 2004-05-26 2016-09-14 伊诺泰克制药公司 嘌呤衍生物作为腺苷a1受体激动剂及其用法
EA015683B1 (ru) * 2005-11-30 2011-10-31 Инотек Фармасьютикалз Корпорейшн Производные пурина и способы их применения
LT2523669T (lt) 2010-01-11 2017-04-25 Inotek Pharmaceuticals Corporation Akispūdžio mažinimo būdas, derinys ir rinkinys
PH12012501906A1 (en) 2010-03-26 2013-01-14 Inotek Pharmaceuticals Corp Method of reducing intraocular pressure in humans using n6 -cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof
PT2807178T (pt) 2012-01-26 2017-08-08 Inotek Pharmaceuticals Corp Polimorfos anidros de nitrato de (2r,3s,4r,5r)-5-(6-(ciclopentilamino)-9h-purin-9-il)-3,4-dihidroxitetrahidrofuran-2-il)}metilo e seus processos de preparação
NZ630759A (en) 2013-03-15 2017-07-28 Inotek Pharmaceuticals Corp Ophthalmic formulations comprising an a1 agonist
JP2022538408A (ja) * 2019-06-21 2022-09-02 アカデミー オブ ミリタリー メディカル サイエンシズ A2aアデノシン受容体アゴニスト活性を有する6-ヒドラジノアデノシン化合物

Also Published As

Publication number Publication date
JPS4935635B1 (https=) 1974-09-25
FR2120040A1 (https=) 1972-08-11
DE2163790A1 (de) 1972-07-20
US3819613A (en) 1974-06-25
NL7117787A (https=) 1972-06-30
CA952102A (en) 1974-07-30
BE777223A (fr) 1972-06-23

Similar Documents

Publication Publication Date Title
FR2105256A1 (https=)
FR2104809B3 (https=)
FR2103410A1 (https=)
FR2095299B1 (https=)
FR2107884B1 (https=)
FR2102173A1 (https=)
FR2086329A1 (https=)
FR2098461A1 (https=)
JPS4935635B1 (https=)
FR2103234A5 (https=)
FR2108238A5 (https=)
FR2088489A1 (https=)
FR2101197B1 (https=)
FR2107456A5 (https=)
FR2107498A5 (https=)
FR2107846B1 (https=)
FR2104768A1 (https=)
FR2104311A5 (https=)
FR2098164B1 (https=)
FR2103182A5 (https=)
FR2103443B1 (https=)
FR2087946A5 (https=)
FR2107554A5 (https=)
FR2098854A5 (https=)
FR2097527A5 (https=)